Chronix Biomedical, Inc. (Chronix Biomedical) is a molecular diagnostic company that develops blood tests for monitoring minimal residual disease in cancer patients. The company offers tests, which include second opinion tests and delta dot tests. Its second opinion tests include supplementary blood tests that can reduce patient anxiety and adverse side effects. Chronix Biomedical provides delta dot test, which monitor blood plasma cancer fingerprints during therapy treatment. It offers research and development services. The company’s technologies include apoptosis, specific cancer DNA, and multi-cancer biomarkers. Chronix Biomedical is headquartered in San Jose, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Chronix Biomedical, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reason To Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Chronix Biomedical, Inc. Company Snapshot 7
Chronix Biomedical, Inc. Company Overview 7
Chronix Biomedical, Inc. Pipeline Products and Clinical Trials Overview 8
Chronix Biomedical, Inc. – Pipeline Analysis Overview 11
Key Facts 11
Chronix Biomedical, Inc. - Major Products and Services 12
Chronix Biomedical, Inc. Pipeline Products by Development Stage 13
Chronix Biomedical, Inc. Pipeline Products Overview 15
Companion Diagnostic Test - Alzheimer’s Disease 15
Companion Diagnostic Test - Alzheimer’s Disease Product Overview 15
Companion Diagnostic Test - Amyloidosis 16
Companion Diagnostic Test - Amyloidosis Product Overview 16
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis 17
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis Product Overview 17
Companion Diagnostic Test - Autism Spectrum Disorders 18
Companion Diagnostic Test - Autism Spectrum Disorders Product Overview 18
Companion Diagnostic Test - Brain Cancer 19
Companion Diagnostic Test - Brain Cancer Product Overview 19
Companion Diagnostic Test - Breast Cancer 20
Companion Diagnostic Test - Breast Cancer Product Overview 20
Companion Diagnostic Test - Chronic Fatigue Syndrome 21
Companion Diagnostic Test - Chronic Fatigue Syndrome Product Overview 21
Companion Diagnostic Test - Colorectal Cancer 22
Companion Diagnostic Test - Colorectal Cancer Product Overview 22
Companion Diagnostic Test - Gulf War Illnesses 23
Companion Diagnostic Test - Gulf War Illnesses Product Overview 23
Companion Diagnostic Test - HPV 24
Companion Diagnostic Test - HPV Product Overview 24
Companion Diagnostic Test - Huntington's Disease 25
Companion Diagnostic Test - Huntington's Disease Product Overview 25
Companion Diagnostic Test - Lung Cancer 26
Companion Diagnostic Test - Lung Cancer Product Overview 26
Companion Diagnostic Test - Multiple Sclerosis 27
Companion Diagnostic Test - Multiple Sclerosis Product Overview 27
Companion Diagnostic Test - Ovarian Cancer 28
Companion Diagnostic Test - Ovarian Cancer Product Overview 28
Companion Diagnostic Test - Pancreatic Cancer 29
Companion Diagnostic Test - Pancreatic Cancer Product Overview 29
Companion Diagnostic Test - Parkinson’s Disease 30
Companion Diagnostic Test - Parkinson’s Disease Product Overview 30
Companion Diagnostic Test - Prostate Cancer 31
Companion Diagnostic Test - Prostate Cancer Product Overview 31
Companion Diagnostic Test - Rheumatoid Arthritis 32
Companion Diagnostic Test - Rheumatoid Arthritis Product Overview 32
Companion Diagnostic Test - Systemic Lupus Erythematous 33
Companion Diagnostic Test - Systemic Lupus Erythematous Product Overview 33
Companion Diagnostic Test - Type I Diabetes 34
Companion Diagnostic Test - Type I Diabetes Product Overview 34
Chronix Biomedical, Inc. - Key Competitors 35
Chronix Biomedical, Inc. - Key Employees 36
Chronix Biomedical, Inc. - Locations And Subsidiaries 37
Head Office 37
Recent Developments 38
Chronix Biomedical, Inc., Recent Developments 38
Apr 18, 2016: Changes in tumor cell-free DNA copy number instability predict therapeutic response in metastatic cancers 38
Oct 20, 2015: Chronix Biomedical: First Patient in the World Shows Utility of Brand New Cancer Test 38
Jul 15, 2015: Chronix Biomedical: Appointment of Nick Plowman, MD, FRCR, FRCP, as Chief Oncology Expert and Member of Medical Advisory Board 39
May 30, 2014: New Test Increases Sensitivity of HPV Detection in Cancer 39
Mar 07, 2012: Chronix Biomedical Opens Mass Sequencing Laboratory To Provide Medical Researchers With Personal Biomarkers In Human Disease 40
Jun 07, 2010: Data Presented At ASCO Show Chronix Biomedical’s DNA Blood Tests Detect Breast And Prostate Cancer With 92% Sensitivity And 100% Specificity 41
Apr 06, 2010: New Data Shows Utility Of Chronix Biomedical's Serum DNA Tests In Multiple Sclerosis 42
Mar 09, 2010: New Study Shows Chronix Biomedical's Serum DNA Assays Can Detect Early-Stage Breast Cancer 43
Jul 15, 2009: Chronix Biomedical Appoints Paul E. Freiman As Chairman 43
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Tables
List of Tables
Chronix Biomedical, Inc. Pipeline Products and Clinical Trials Overview 8
Chronix Biomedical, Inc. Pipeline Products by Equipment Type 8
Chronix Biomedical, Inc. Pipeline Products by Indication 10
Chronix Biomedical, Inc., Key Facts 11
Chronix Biomedical, Inc., Major Products and Services 12
Chronix Biomedical, Inc. Number of Pipeline Products by Development Stage 13
Chronix Biomedical, Inc. Pipeline Products Summary by Development Stage 14
Companion Diagnostic Test - Alzheimer’s Disease - Product Status 15
Companion Diagnostic Test - Alzheimer’s Disease - Product Description 15
Companion Diagnostic Test - Amyloidosis - Product Status 16
Companion Diagnostic Test - Amyloidosis - Product Description 16
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Status 17
Companion Diagnostic Test - Amyotrophic Lateral Sclerosis - Product Description 17
Companion Diagnostic Test - Autism Spectrum Disorders - Product Status 18
Companion Diagnostic Test - Autism Spectrum Disorders - Product Description 18
Companion Diagnostic Test - Brain Cancer - Product Status 19
Companion Diagnostic Test - Brain Cancer - Product Description 19
Companion Diagnostic Test - Breast Cancer - Product Status 20
Companion Diagnostic Test - Breast Cancer - Product Description 20
Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Status 21
Companion Diagnostic Test - Chronic Fatigue Syndrome - Product Description 21
Companion Diagnostic Test - Colorectal Cancer - Product Status 22
Companion Diagnostic Test - Colorectal Cancer - Product Description 22
Companion Diagnostic Test - Gulf War Illnesses - Product Status 23
Companion Diagnostic Test - Gulf War Illnesses - Product Description 23
Companion Diagnostic Test - HPV - Product Status 24
Companion Diagnostic Test - HPV - Product Description 24
Companion Diagnostic Test - Huntington's Disease - Product Status 25
Companion Diagnostic Test - Huntington's Disease - Product Description 25
Companion Diagnostic Test - Lung Cancer - Product Status 26
Companion Diagnostic Test - Lung Cancer - Product Description 26
Companion Diagnostic Test - Multiple Sclerosis - Product Status 27
Companion Diagnostic Test - Multiple Sclerosis - Product Description 27
Companion Diagnostic Test - Ovarian Cancer - Product Status 28
Companion Diagnostic Test - Ovarian Cancer - Product Description 28
Companion Diagnostic Test - Pancreatic Cancer - Product Status 29
Companion Diagnostic Test - Pancreatic Cancer - Product Description 29
Companion Diagnostic Test - Parkinson’s Disease - Product Status 30
Companion Diagnostic Test - Parkinson’s Disease - Product Description 30
Companion Diagnostic Test - Prostate Cancer - Product Status 31
Companion Diagnostic Test - Prostate Cancer - Product Description 31
Companion Diagnostic Test - Rheumatoid Arthritis - Product Status 32
Companion Diagnostic Test - Rheumatoid Arthritis - Product Description 32
Companion Diagnostic Test - Systemic Lupus Erythematous - Product Status 33
Companion Diagnostic Test - Systemic Lupus Erythematous - Product Description 33
Companion Diagnostic Test - Type I Diabetes - Product Status 34
Companion Diagnostic Test - Type I Diabetes - Product Description 34
Chronix Biomedical, Inc., Key Employees 36
List of Figures
List of Figures
Chronix Biomedical, Inc. Pipeline Products by Equipment Type 9
Chronix Biomedical, Inc. Pipeline Products by Development Stage 13